{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:57:54Z","timestamp":1794070674529,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Mobile applications (apps) have proven to be highly effective tools to empower patients with type 1 diabetes mellitus (T1DM) and enable them to achieve better self-care, quality of life (QOL), and glycemic control. The aim of the study is to examine whether mySugr\n                      <jats:sup>\u00ae<\/jats:sup>\n                      , an app for diabetes management, together with teleconsultations, can have a positive impact on these factors and, thereby, replace current clinical care.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study concerns an exploratory randomized clinical trial of 12 months\u2019 duration. People with T1DM using multiple daily injections were randomized to usual care (bolus calculator, five face-to-face visits) or intervention (mySugr\n                      <jats:sup>\u00ae<\/jats:sup>\n                      app, three face-to-face visits, and two teleconsultations). The main outcome was increase in empowerment assessed with the Diabetes Empowerment Scale Short Form questionnaire (DES-SF-S). Secondary outcomes were change in additional glucose-related (blood glucose monitoring, mean blood glucose, standard deviation, coefficient of variation (CV), and high and low blood glucose index) and patient-reported outcome measures (PROMs) (self-management, QOL, and distress).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 25 out of 28 participants completed the study (52% men, age 44.52 years, diabetes duration 21.28 years). At 12 months, no significant differences were identified in the change of DES-SF-S and additional PROMs between arms. Similarly, no differences were observed in glucose-related outcomes except for the change in CV at 9 (control \u2212\u20091.87\u2009\u00b1\u20094.98 vs. intervention 5.89\u2009\u00b1\u200911.33,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) and 12 months (control \u2212\u20092.33\u2009\u00b1\u20093.54 vs. intervention 5.12\u2009\u00b1\u200911.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018). Adherence to and satisfaction with the app were high.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Patients with diabetes using the mySugr\n                      <jats:sup>\u00ae<\/jats:sup>\n                      app and teleconsultation achieved similar results to those following usual care in empowerment, other PROMs, and most glucose-related outcomes, thus supporting its use in combination with face-to-face visits. The RCT was registered with ClinicalTrials.gov (NCT03819335, first registration 28\/01\/2019).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s42000-024-00609-z","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T03:01:43Z","timestamp":1729047703000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr\u00ae app"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-7441","authenticated-orcid":false,"given":"Gemma","family":"Cuixart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Corcoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"609_CR1","unstructured":"World Health Organization. Diabetes. Accessed 16 February 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes"},{"issue":"12","key":"609_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1464-5491.2004.01386.x","volume":"21","author":"JH Devries","year":"2004","unstructured":"Devries JH, Snoek FJ, Heine RJ (2004) Persistent poor glycaemic control in adult type 1 diabetes. A closer look at the problem. Diabet Med 21(12):1263\u20131268. https:\/\/doi.org\/10.1111\/j.1464-5491.2004.01386.x","journal-title":"Diabet Med"},{"issue":"3","key":"609_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1742-1241.2009.02296.x","volume":"64","author":"P Aschner","year":"2010","unstructured":"Aschner P, Horton E, Leiter LA, Munro N, Skyler JS, Global Partnership for Effective Diabetes Management (2010) Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management. Int J Clin Pract 64(3):305\u2013315. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02296.x","journal-title":"Int J Clin Pract"},{"issue":"9","key":"609_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1089\/dia.2021.0080","volume":"23","author":"JM Lee","year":"2021","unstructured":"Lee JM, Carlson E, Albanese-O\u2019Neill A et al (2021) Adoption of Telemedicine for Type 1 Diabetes Care during the COVID-19 pandemic. Diabetes Technol Ther 23(9):642\u2013651. https:\/\/doi.org\/10.1089\/dia.2021.0080","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"609_CR5","doi-asserted-by":"publisher","first-page":"e00180","DOI":"10.1002\/edm2.180","volume":"4","author":"SN Scott","year":"2020","unstructured":"Scott SN, Fontana FY, Z\u00fcger T, Laimer M, Stettler C (2020) Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-results of a global survey. Endocrinol Diabetes Metab 4(1):e00180. https:\/\/doi.org\/10.1002\/edm2.180","journal-title":"Endocrinol Diabetes Metab"},{"issue":"10","key":"609_CR6","doi-asserted-by":"publisher","first-page":"e4197","DOI":"10.1210\/clinem\/dgac4768","volume":"107","author":"T Kaushal","year":"2022","unstructured":"Kaushal T, Tinsley LJ, Volkening LK, Turcotte C, Laffel LM (2022) Improved CGM glucometrics and more visits for Pediatric Type 1 diabetes using Telemedicine during 1 year of COVID-19. J Clin Endocrinol Metab 107(10):e4197\u2013e4202. https:\/\/doi.org\/10.1210\/clinem\/dgac4768","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"609_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10916-016-0492-7","volume":"40","author":"SS Bhuyan","year":"2016","unstructured":"Bhuyan SS, Lu N, Chandak A et al (2016) Use of Mobile Health Applications for Health-seeking Behavior among US adults. J Med Syst 40(6):153. https:\/\/doi.org\/10.1007\/s10916-016-0492-7","journal-title":"J Med Syst"},{"key":"609_CR8","doi-asserted-by":"publisher","first-page":"205520761988218","DOI":"10.1177\/2055207619882181","volume":"5","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Kedia S, Wyant DK, Ahn S, Bhuyan SS (2019) Use of mobile health applications for health-promoting behavior among individuals with chronic medical conditions. Digit Health 5:2055207619882181. https:\/\/doi.org\/10.1177\/2055207619882181","journal-title":"Digit Health"},{"issue":"4","key":"609_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1464-5491.2010.03180.x","volume":"28","author":"X Liang","year":"2011","unstructured":"Liang X, Wang Q, Yang X et al (2011) Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med 28(4):455\u2013463. https:\/\/doi.org\/10.1111\/j.1464-5491.2010.03180.x","journal-title":"Diabet Med"},{"issue":"11","key":"609_CR10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2337\/dc16-0346","volume":"39","author":"C Hou","year":"2016","unstructured":"Hou C, Carter B, Hewitt J, Francisa T, Mayor S (2016) Do Mobile phone applications improve Glycemic Control (HbA1c) in the self-management of diabetes? A systematic review, Meta-analysis, and GRADE of 14 randomized trials. Diabetes Care 39(11):2089\u20132095. https:\/\/doi.org\/10.2337\/dc16-0346","journal-title":"Diabetes Care"},{"issue":"8","key":"609_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/dom.13307","volume":"20","author":"C Hou","year":"2018","unstructured":"Hou C, Xu Q, Diao S, Hewitt J, Li J, Carter B (2018) Mobile phone applications and self-management of diabetes: a systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE. Diabetes Obes Metab 20(8):2009\u20132013. https:\/\/doi.org\/10.1111\/dom.13307","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"609_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/dc09-1327","volume":"33","author":"MC Rossi","year":"2010","unstructured":"Rossi MC, Nicolucci A, Di Bartolo P et al (2010) Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care 33(1):109\u2013115. https:\/\/doi.org\/10.2337\/dc09-1327","journal-title":"Diabetes Care"},{"issue":"8","key":"609_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/dia.2013.0021","volume":"15","author":"MC Rossi","year":"2013","unstructured":"Rossi MC, Nicolucci A, Lucisano G et al (2013) Impact of the Diabetes Interactive Diary telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes. Diabetes Technol Ther 15(8):670\u2013679. https:\/\/doi.org\/10.1089\/dia.2013.0021","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"609_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1357633X16631628","volume":"23","author":"JS Baron","year":"2017","unstructured":"Baron JS, Hirani S, Newman SP (2017) A randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes. J Telemed Telecare 23(2):207\u2013216. https:\/\/doi.org\/10.1177\/1357633X16631628","journal-title":"J Telemed Telecare"},{"issue":"5","key":"609_CR15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1177\/1932296815585871","volume":"9","author":"I Drion","year":"2015","unstructured":"Drion I, Pameijer LR, van Dijk PR, Groenier KH, Kleefstra N, Bilo HJ (2015) The effects of a Mobile phone application on quality of life in patients with type 1 diabetes Mellitus: a randomized controlled trial. J Diabetes Sci Technol 9(5):1086\u20131091. https:\/\/doi.org\/10.1177\/1932296815585871","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"609_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2337\/dc10-1259","volume":"34","author":"G Charpentier","year":"2011","unstructured":"Charpentier G, Benhamou PY, Dardari D et al (2011) The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 study). Diabetes Care 34(3):533\u2013539. https:\/\/doi.org\/10.2337\/dc10-1259","journal-title":"Diabetes Care"},{"issue":"11","key":"609_CR17","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.2196\/jmir.2588","volume":"15","author":"M Kirwan","year":"2013","unstructured":"Kirwan M, Vandelanotte C, Fenning A, Duncan MJ (2013) Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J Med Internet Res 15(11):e235. https:\/\/doi.org\/10.2196\/jmir.2588","journal-title":"J Med Internet Res"},{"key":"609_CR18","doi-asserted-by":"publisher","unstructured":"Zhou W, Chen M, Yuan J, Sun Y, Welltang (2016) A smart phone-based diabetes management application - improves blood glucose control in Chinese people with diabetes. Diabetes Res Clin Pract 116:105\u2013110. https:\/\/doi.org\/10.1016\/j.diabres.2016.03.018","DOI":"10.1016\/j.diabres.2016.03.018"},{"issue":"1","key":"609_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1051\/tpe\/2009002","volume":"1","author":"RM Anderson","year":"2009","unstructured":"Anderson RM, Funnell MM, Aikens JE et al (2009) Evaluating the efficacy of an empowerment-based self-management consultant intervention: results of a two-year randomized controlled trial. Ther Patient Educ 1(1):3\u201311. https:\/\/doi.org\/10.1051\/tpe\/2009002","journal-title":"Ther Patient Educ"},{"issue":"4","key":"609_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/0145721710371524","volume":"36","author":"A Castillo","year":"2010","unstructured":"Castillo A, Giachello A, Bates R et al (2010) Community-based Diabetes Education for latinos: the diabetes empowerment education program. Diabetes Educ 36(4):586\u2013594. https:\/\/doi.org\/10.1177\/0145721710371524","journal-title":"Diabetes Educ"},{"issue":"1","key":"609_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pcd.2009.01.001","volume":"3","author":"LN McEwen","year":"2009","unstructured":"McEwen LN, Kim C, Haan MN et al (2009) Are health-related quality-of-life and self-rated health associated with mortality? Insights from translating Research Into Action for Diabetes (TRIAD). Prim Care Diabetes 3(1):37\u201342. https:\/\/doi.org\/10.1016\/j.pcd.2009.01.001","journal-title":"Prim Care Diabetes"},{"issue":"12","key":"609_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1089\/dia.2017.0235","volume":"19","author":"S Trawley","year":"2017","unstructured":"Trawley S, Baptista S, Browne JL, Pouwer F, Speight J (2017) The Use of Mobile Applications among adults with type 1 and type 2 diabetes: results from the Second MILES-Australia (MILES-2) study. Diabetes Technol Ther 19(12):730\u2013738. https:\/\/doi.org\/10.1089\/dia.2017.0235","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"609_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10916-016-0564-8","volume":"40","author":"PP Brzan","year":"2016","unstructured":"Brzan PP, Rotman E, Pajnkihar M, Klanjsek P (2016) Mobile Applications for Control and Self Management of diabetes: a systematic review. J Med Syst 40(9):210. https:\/\/doi.org\/10.1007\/s10916-016-0564-8","journal-title":"J Med Syst"},{"issue":"6","key":"609_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2337\/diacare.23.6.739","volume":"23","author":"RM Anderson","year":"2000","unstructured":"Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG (2000) The diabetes empowerment scale: a measure of psychosocial self-efficacy. Diabetes Care 23(6):739\u2013743. https:\/\/doi.org\/10.2337\/diacare.23.6.739","journal-title":"Diabetes Care"},{"issue":"5","key":"609_CR25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2337\/diacare.26.5.1641-a","volume":"26","author":"RM Anderson","year":"2003","unstructured":"Anderson RM, Fitzgerald JT, Gruppen LD, Funnell MM, Oh MS (2003) The diabetes empowerment scale-short form (DES-SF). Diabetes Care 26(5):1641\u20131642. https:\/\/doi.org\/10.2337\/diacare.26.5.1641-a","journal-title":"Diabetes Care"},{"key":"609_CR26","doi-asserted-by":"publisher","unstructured":"(1988) Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 11(9):725\u2013732. https:\/\/doi.org\/10.2337\/diacare.11.9.725","DOI":"10.2337\/diacare.11.9.725"},{"key":"609_CR27","doi-asserted-by":"publisher","unstructured":"Millan M (2002) Cuestionario de calidad de vida espec\u00edfico para la diabetes mellitus (EsDQOL) [Quality-of-life questionnaire designed for diabetes mellitus (EsDQOL)]. Aten Primaria May 15;29(8):517\u2013\u200921. Spanish. https:\/\/doi.org\/10.1016\/s0212-6567(02)70623-9","DOI":"10.1016\/s0212-6567(02)70623-9"},{"issue":"3","key":"609_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diacare.28.3.626","volume":"28","author":"WH Polonsky","year":"2005","unstructured":"Polonsky WH, Fisher L, Earles J et al (2005) Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care 28(3):626\u2013631. https:\/\/doi.org\/10.2337\/diacare.28.3.626","journal-title":"Diabetes Care"},{"issue":"12","key":"609_CR29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/j.1464-5491.2006.01989.x","volume":"23","author":"VL Franklin","year":"2006","unstructured":"Franklin VL, Waller A, Pagliari C, Greene SA (2006) A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 23(12):1332\u20131338. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01989.x","journal-title":"Diabet Med"},{"issue":"8","key":"609_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1464-5491.2002.00791.x","volume":"19","author":"L Howells","year":"2002","unstructured":"Howells L, Wilson AC, Skinner TC, Newton R, Morris AD, Greene SA (2002) A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with type 1 diabetes. Diabet Med Aug 19(8):643\u2013648. https:\/\/doi.org\/10.1046\/j.1464-5491.2002.00791.x","journal-title":"Diabet Med Aug"},{"issue":"4","key":"609_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/dia.2008.0063","volume":"11","author":"KP McCarrier","year":"2009","unstructured":"McCarrier KP, Ralston JD, Hirsch IB et al (2009) Web-based collaborative care for type 1 diabetes: a pilot randomized trial. Diabetes Technol Ther Apr 11(4):211\u2013217. https:\/\/doi.org\/10.1089\/dia.2008.0063","journal-title":"Diabetes Technol Ther Apr"},{"key":"609_CR32","doi-asserted-by":"publisher","unstructured":"Dobson R, Whittaker R, Jiang Y et al (2018) Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ May 17;361:k1959. https:\/\/doi.org\/10.1136\/bmj.k1959","DOI":"10.1136\/bmj.k"},{"issue":"S2","key":"609_CR33","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1089\/dia.2019.0019","volume":"21","author":"F Debong","year":"2019","unstructured":"Debong F, Mayer H, Kober J (2019) Real-world assessments of mySugr Mobile Health App. Diabetes Technol Ther Jun 21(S2):S235\u2013S240. https:\/\/doi.org\/10.1089\/dia.2019.0019","journal-title":"Diabetes Technol Ther Jun"},{"key":"609_CR34","unstructured":"Centro Nacional de Epidemiolog\u00eda. COVID-19 en Espa\u00f1a. Accessed 2 (2021) https:\/\/cnecovid.isciii.es\/"},{"issue":"6","key":"609_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1192\/bjp.2020.212","volume":"218","author":"R O\u2019Connor","year":"2021","unstructured":"O\u2019Connor R, Wetherall K, Cleare S et al (2021) Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Br J Psychiatry 218(6):326\u2013333. https:\/\/doi.org\/10.1192\/bjp.2020.212","journal-title":"Br J Psychiatry"},{"key":"609_CR36","doi-asserted-by":"publisher","unstructured":"Hompesch M, Hergesheimer L, Kalcher K, Debong F et al (2017) Retrospective analysis of Impact on SMBG and Glycemic Control of Mobile Health (MHealth)-Application for Diabetes Management. 2016 Diabetes Technology Meeting Abstracts. J Diabetes Sci Technol Mar 1;11(2):346\u2013437. https:\/\/doi.org\/10.1177\/1932296817696371","DOI":"10.1177\/1932296817696371"},{"issue":"12","key":"609_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11892-015-0680-8","volume":"15","author":"LF Garabedian","year":"2015","unstructured":"Garabedian LF, Ross-Degnan D, Wharam JF (2015) Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management. Curr Diab Rep Dec 15(12):109. https:\/\/doi.org\/10.1007\/s11892-015-0680-8","journal-title":"Curr Diab Rep Dec"},{"issue":"1","key":"609_CR38","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2337\/dc19-1214","volume":"43","author":"KM Miller","year":"2020","unstructured":"Miller KM, Hermann J, Foster N, Registries DPV et al (2020) Longitudinal changes in continuous glucose monitoring use among individuals with type 1 diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange registries. Diabetes Care Jan 43(1):e1\u2013e2. https:\/\/doi.org\/10.2337\/dc19-1214","journal-title":"Diabetes Care Jan"},{"key":"609_CR39","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee (2022); 6. Glycemic Targets: Standards of Medical Care in Diabetes\u20142022. Diabetes Care 1 January; 45 (Supplement_1): S83\u2013S96. https:\/\/doi.org\/10.2337\/dc22-S006","DOI":"10.2337\/dc22-S006"},{"key":"609_CR40","unstructured":"National Clinical Guideline Centre (UK) (2015). Type 1 diabetes in adults: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); Aug. PMID: 26334079"},{"key":"609_CR41","doi-asserted-by":"publisher","first-page":"e000342","DOI":"10.1136\/bmjdrc-2016-000342","volume":"5","author":"P Mostr\u00f6m","year":"2017","unstructured":"Mostr\u00f6m P, Ahl\u00e9n E, Imberg H et al (2017) Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes Res Care 5:e000342. https:\/\/doi.org\/10.1136\/bmjdrc-2016-000342","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00609-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:53:19Z","timestamp":1742201599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00609-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00609-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4108219\/v1","asserted-by":"object"}]},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest with respect to the research, authorship, and\/or publication of this article. Roche Diabetes Care\n                      \u00ae\n                      did not play any role in the study, as indicated under Funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}